头颈癌病史预测下咽鳞癌经口视频喉镜术后复发及第二原发肿瘤
本研究回顾性分析84例早期下咽鳞状细胞癌患者接受经口视频喉镜手术(TOVS)后的结局,中位随访49.3个月。既往头颈鳞癌病史独立预测TOVS后头颈鳞癌事件(局部复发或第二原发)的无事件生存更差(HR 4.3,95%CI 2.3-8.0;p<0.0001),支持风险适配的监测策略。
要点
- 既往头颈鳞癌病史是TOVS后无事件生存的独立预测因素(HR 4.3)。
- 有既往头颈鳞癌者2年无事件生存仅23.0%,无者为73.8%。
- 总生存和病因特异性生存在有/无既往头颈鳞癌者间相当。
核心结论
- 既往头颈鳞癌病史是TOVS后无事件生存的最主要预测因素,支持风险适配的监测。
研究设计与样本
- 单中心、高手术量中心回顾性队列研究,纳入84例接受TOVS治疗的早期下咽鳞状细胞癌患者。
主要发现
- 中位随访49.3个月,2年无事件生存率49.0%,2年总生存率93.8%,2年病因特异性生存率100%。
- 既往头颈鳞癌病史独立预测更差的无事件生存(HR 4.3,95%CI 2.3-8.0;p<0.0001)。
- 有既往头颈鳞癌者2年无事件生存率23.0%,无者为73.8%;总生存和病因特异性生存两组相当。
临床怎么用
- 对TOVS术后早期下咽鳞癌患者,应依据既往头颈鳞癌病史进行风险分层监测。
局限性
- 回顾性单中心设计,样本量84例,随访时间有限,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surveillance after transoral videolaryngoscopic surgery (TOVS) for early-stage hypopharyngeal squamous cell carcinoma (HPSCC) remains unvalidated, particularly regarding posttreatment local recurrence and second primary head and neck squamous cell carcinoma (HNSCC). METHODS: We retrospectively reviewed 84 patients with early-stage HPSCC treated with TOVS at a single high-volume center. Post-TOVS "HNSCC events" were defined as local recurrence or second primary HNSCC diagnosed after TOVS. Event-free survival (EFS) was defined as time to first post-TOVS HNSCC event or death. RESULTS: Median follow-up was 49.3 months. Two-year EFS and overall survival (OS) were 49.0% and 93.8%, and 2-year cause-specific survival was 100%. Prior HNSCC before the index HPSCC independently predicted worse EFS (HR 4.3, 95% CI 2.3-8.0; p < 0.0001): 2-year EFS was 73.8% without versus 23.0% with prior HNSCC, while OS and cause-specific survival were comparable. CONCLUSIONS: Prior HNSCC is the dominant predictor of post-TOVS EFS, supporting risk-adapted surveillance.
引用
- Katoh M, Eguchi K, Ito T, et al. History of Head and Neck Cancer as a Predictor of Recurrence and Second Primary Tumors After Transoral Videolaryngoscopic Surgery in Patients With Hypopharyngeal Squamous Cell Carcinoma. Head Neck. 2026. PMID: 41860472. doi:10.1002/hed.70242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。